In 2023, the Federal Trade Commission fined GoodRx $1.5 million for sharing prescription data with advertisers - a precedent that shook the entire digital health sector
Significant reductions in sleep apnea severity typically emerge at 812 weeks as cumulative weight loss reaches 510%
Notably, SGLT2i have also been shown to be effective for the treatment of patients with HFmrEF and HFpEF, with their efficacy independent of ejection fraction
The numbers are staggering
Growth Opportunity Mapping across drug types (Semaglutide, Exenatide, Lixisenatide, Liraglutide, Dulaglutide, Others), routes of administration (Oral, Parenteral), indications (Diabetes, Obesity, Others), and regions